Tianjun Jiang

1.4k total citations
21 papers, 227 citations indexed

About

Tianjun Jiang is a scholar working on Epidemiology, Virology and Infectious Diseases. According to data from OpenAlex, Tianjun Jiang has authored 21 papers receiving a total of 227 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 8 papers in Virology and 7 papers in Infectious Diseases. Recurrent topics in Tianjun Jiang's work include HIV Research and Treatment (7 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Immune Cell Function and Interaction (3 papers). Tianjun Jiang is often cited by papers focused on HIV Research and Treatment (7 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Immune Cell Function and Interaction (3 papers). Tianjun Jiang collaborates with scholars based in China, Sierra Leone and United States. Tianjun Jiang's co-authors include Fu‐Sheng Wang, Ji‐Yuan Zhang, Chao Zhang, Yan‐Mei Jiao, Qing‐Lei Zeng, Bing Song, Zhe Xu, Min Zhao, Lei Huang and Jinsong Mu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Tianjun Jiang

19 papers receiving 224 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tianjun Jiang China 10 97 82 54 49 38 21 227
Paola Zuccalà Italy 8 77 0.8× 125 1.5× 130 2.4× 40 0.8× 36 0.9× 13 278
Charlotte Pronier France 9 126 1.3× 176 2.1× 54 1.0× 24 0.5× 10 0.3× 29 305
Camilla Ajassa Italy 8 123 1.3× 65 0.8× 8 0.1× 32 0.7× 14 0.4× 27 223
Agnieszka Bednarska Poland 7 67 0.7× 184 2.2× 174 3.2× 23 0.5× 35 0.9× 20 282
Giuseppe Bruno Italy 10 102 1.1× 96 1.2× 47 0.9× 34 0.7× 93 2.4× 26 253
Rui Sarmento‐Castro Portugal 8 80 0.8× 81 1.0× 34 0.6× 30 0.6× 54 1.4× 18 180
Shujing Song China 9 187 1.9× 124 1.5× 93 1.7× 48 1.0× 3 0.1× 23 326
Nils Postel Germany 7 159 1.6× 99 1.2× 23 0.4× 9 0.2× 12 0.3× 9 256
Beatriz Álvarez Spain 6 59 0.6× 31 0.4× 28 0.5× 29 0.6× 32 0.8× 18 126
Marco Vecchia Italy 6 181 1.9× 25 0.3× 16 0.3× 107 2.2× 10 0.3× 17 290

Countries citing papers authored by Tianjun Jiang

Since Specialization
Citations

This map shows the geographic impact of Tianjun Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianjun Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianjun Jiang more than expected).

Fields of papers citing papers by Tianjun Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianjun Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianjun Jiang. The network helps show where Tianjun Jiang may publish in the future.

Co-authorship network of co-authors of Tianjun Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Tianjun Jiang. A scholar is included among the top collaborators of Tianjun Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianjun Jiang. Tianjun Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xinhua, Bing Song, Tianjun Jiang, et al.. (2024). Retrospective Study on Genetic Diversity and Drug Resistance among People Living with HIV at an AIDS Clinic in Beijing. Pharmaceuticals. 17(1). 115–115. 2 indexed citations
2.
Li, Yonggang, Zhe Xu, Yuanyuan Li, et al.. (2024). Preclinical and phase I studies of an antisense oligonucleotide drug targeting IGF-1R in liver cancer. Future Oncology. 20(34). 2671–2684. 1 indexed citations
3.
Song, Bing, Juan Cheng, Jing Tian, et al.. (2024). Safety Profile of COVID-19 Vaccines in HIV Patients Undergoing ART and Their Impact on Immune Recovery and HIV Reservoirs. SHILAP Revista de lepidopterología. 4(4). 178–186.
5.
Xia, Peng, Xudong Xing, Cuixian Yang, et al.. (2022). Activation-induced pyroptosis contributes to the loss of MAIT cells in chronic HIV-1 infected patients. Military Medical Research. 9(1). 24–24. 29 indexed citations
6.
Huang, Huihuang, Bing Song, Linbo Gao, et al.. (2022). Incidence of and risk factors for liver damage in patients with HIV‐1 mono‐infection receiving antiretroviral therapy. HIV Medicine. 23(S1). 14–22. 3 indexed citations
7.
Xu, Ruonan, Jiyuan Zhang, Bo Tu, et al.. (2021). HLA-mismatched allogeneic adoptive immune therapy in severely immunosuppressed AIDS patients. Signal Transduction and Targeted Therapy. 6(1). 174–174. 3 indexed citations
8.
Li, Bowen, Xing Fan, Wenjing Cao, et al.. (2021). Systematic Discovery and Pathway Analyses of Metabolic Disturbance in COVID-19. SHILAP Revista de lepidopterología. 1(2). 74–85. 4 indexed citations
9.
Liu, Fangfang, Chengcheng Ji, Jiajun Luo, et al.. (2020). Clinical characteristics and corticosteroids application of different clinical types in patients with corona virus disease 2019. Scientific Reports. 10(1). 13689–13689. 32 indexed citations
10.
Huang, Huihuang, Bing Song, Zhe Xu, et al.. (2020). Predictors of Coronavirus Disease 2019 Severity: A Retrospective Study of 64 Cases. Japanese Journal of Infectious Diseases. 74(1). 54–60. 23 indexed citations
11.
Ye, Jingrong, Hui Xing, Fujie Zhang, et al.. (2019). Transmitted HIV drug resistance among individuals with newly diagnosed HIV infection: a multicenter observational study. AIDS. 34(4). 609–619. 19 indexed citations
12.
Huang, Lei, Jijing Shi, Yan‐Mei Jiao, et al.. (2019). Skewed CD39/CD73/adenosine pathway in B cells is associated with innate immune hyperactivation in chronic HIV-1 infection. SHILAP Revista de lepidopterología. 4(1). 9 indexed citations
13.
Yuan, Yue, Yi Sun, Jing Li, et al.. (2018). Self-Reported Knowledge and Practices of Healthcare Workers on Occupational Exposure and Protection from Infectious Disease at the Military Hospital in Sierra Leone. Journal of medical research/˜The œjournal of medical research. 1 indexed citations
14.
Li, Bo, Xin Zhang, Lei Li, et al.. (2018). Prevalence and associated knowledge of hepatitis B infection among healthcare workers in Freetown, Sierra Leone. BMC Infectious Diseases. 18(1). 35 indexed citations
15.
Shi, Lei, Enqiang Qin, Junnian Zhou, et al.. (2016). HIV and HCV Co-Culture Promotes Profibrogenic Gene Expression through an Epimorphin-Mediated ERK Signaling Pathway in Hepatic Stellate Cells. PLoS ONE. 11(6). e0158386–e0158386. 5 indexed citations
16.
Li, Wengang, Weimin Nie, Weiwei Chen, et al.. (2013). Inhibition of CXCR4 expression by recombinant adenoviruses containing anti-sense RNA resists HIV-1 infection on MT4 cell lines. Gene. 526(2). 443–448. 2 indexed citations
17.
Feng, Guohua, Ji‐Yuan Zhang, Qing‐Lei Zeng, et al.. (2013). HCV-Specific Interleukin-21+CD4+ T Cells Responses Associated with Viral Control through the Modulation of HCV-Specific CD8+ T Cells Function in Chronic Hepatitis C Patients. Molecules and Cells. 36(4). 362–367. 16 indexed citations
18.
Zhang, Ji‐Yuan, Xiaoli Wu, Bin Yang, et al.. (2013). Upregulation of OX40 ligand on monocytes contributes to early virological control in patients with chronic hepatitis C. European Journal of Immunology. 43(7). 1953–1962. 10 indexed citations
19.
Jiang, Tianjun, Ji‐Yuan Zhang, Wengang Li, et al.. (2010). Preferential loss of Th17 cells is associated with CD4 T cell activation in patients with 2009 pandemic H1N1 swine-origin influenza A infection. Clinical Immunology. 137(3). 303–310. 17 indexed citations
20.
Jiang, Tianjun, Min Zhao, Jingmin Zhao, et al.. (2005). [Immunohistochemical evidence for HIV-1 infection in the liver of HIV-infected patients].. PubMed. 19(2). 152–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026